These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11130021)

  • 1. Efficacy of PSA in the detection of carcinoma of the prostate in patients presenting with acute urinary retention.
    McNeill SA; Hargreave TB
    J R Coll Surg Edinb; 2000 Aug; 45(4):227-30. PubMed ID: 11130021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of antibiotics on elevated serum prostate specific antigen in patients with urinary symptoms and negative digital rectal examination: a pilot study.
    Bulbul MA; Wazzan W; Hijaz A; Shaar A
    J Med Liban; 2002; 50(1-2):23-5. PubMed ID: 12841309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between acute urinary retention, chronic prostatic inflammation and accompanying elevated prostate-specific antigen.
    Kefi A; Koseoglu H; Celebi I; Yorukoglu K; Esen A
    Scand J Urol Nephrol; 2006; 40(2):155-60. PubMed ID: 16608815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of acute urinary retention on serum prostate specific antigen concentration].
    Hua LX; Wu HF; Sui YG; Cheng SG; Xu ZQ
    Zhonghua Nan Ke Xue; 2002; 8(2):134-5. PubMed ID: 12479031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S; Cakar B; Conkbayir I; Hekimoglu B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management outcome of acute urinary retention: model of prediction.
    Daly P; Connolly S; Rogers E; Sweeney P
    Urol Int; 2009; 83(1):39-43. PubMed ID: 19641357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of digital rectal examination and prostate specific antigen in detecting carcinoma prostate.
    Iqbal N; Bhatti AN; Husain S
    J Coll Physicians Surg Pak; 2003 Jun; 13(6):340-2. PubMed ID: 12814533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder catheterization and a plasma prostate-specific antigen in patients with benign prostatic hyperplasia and complete urine retention.
    Dutkiewicz S; Stepień K; Witeska A
    Mater Med Pol; 1995; 27(2):71-3. PubMed ID: 8935194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings.
    Luciani LG; De Giorgi G; Valotto C; Zanin M; Bierti S; Zattoni F
    Urology; 2006 Mar; 67(3):555-8. PubMed ID: 16527579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease.
    Freedland SJ; Mangold LA; Epstein JI; Partin AW
    Urology; 2004 May; 63(5):887-91. PubMed ID: 15134972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
    Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
    Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
    Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL.
    Bozeman CB; Carver BS; Caldito G; Venable DD; Eastham JA
    Urology; 2005 Oct; 66(4):803-7. PubMed ID: 16230142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention?
    Tuncel A; Uzun B; Eruyar T; Karabulut E; Seckin S; Atan A
    Eur Urol; 2005 Aug; 48(2):277-83; discussion 283-4. PubMed ID: 15964132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcome of diagnostic transurethral resection of the prostate in patients with elevated prostate-specific antigen level and minor lower urinary tract symptoms.
    van Renterghem K; van Koeveringe G; Achten R; van Kerrebroeck P
    Urol Int; 2009; 83(1):60-5. PubMed ID: 19641361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A; Dworschack RT; Partin AW
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
    Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
    Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
    Lee HM; Hong JH; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered prostate specific antigen reference range after transurethral resection of the prostate.
    Wolff JM; Boekels O; Borchers H; Jakse G; Rohde D
    Anticancer Res; 2000; 20(6D):4977-80. PubMed ID: 11326651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.